Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.
暂无分享,去创建一个
F. McAlister | W. Ghali | R. Tsuyuki | D. Southern | M. Knudtson | P. D. Galbraith | M. Makowsky | P. Galbraith
[1] Deepak L. Bhatt,et al. One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.
[2] Deepak L. Bhatt,et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. , 2006, Journal of the American College of Cardiology.
[3] J. Grimshaw,et al. Implementation Science BioMed Central Study protocol , 2006 .
[4] Á. Avezum,et al. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). , 2006, American heart journal.
[5] Rodney A. White,et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang , 2006, Journal of the American College of Cardiology.
[6] R. Califf,et al. Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease , 2006, Circulation.
[7] Deepak L. Bhatt,et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.
[8] P. Greenland,et al. Atherosclerotic Risk Factors Are Less Intensively Treated in Patients with Peripheral Arterial Disease Than in Patients with Coronary Artery Disease , 1997, Journal of General Internal Medicine.
[9] F. McAlister,et al. Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary. , 2005, The Canadian journal of cardiology.
[10] B. Gersh,et al. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. , 2004, Mayo Clinic proceedings.
[11] D. Malenka,et al. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery. , 2004, The Annals of thoracic surgery.
[12] G. Stone,et al. Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. , 2004, The American journal of cardiology.
[13] J. Knottnerus,et al. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. , 2004, Journal of clinical epidemiology.
[14] G. Stone,et al. Impact of Symptomatic Peripheral Arterial Disease on 1-Year Mortality in Patients Undergoing Percutaneous Coronary Interventions , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[15] K. Eagle,et al. Long-term prognostic implication of extracardiac vascular disease in patients undergoing percutaneous coronary intervention. , 2003, The American journal of cardiology.
[16] E. Topol,et al. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. , 2003, The American journal of cardiology.
[17] Eric J Topol,et al. Critical issues in peripheral arterial disease detection and management: a call to action. , 2003, Archives of internal medicine.
[18] B. Lewis,et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 stu , 2003, American heart journal.
[19] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.
[20] R. Gibbons. ACC/AHA guideline for management of patients with chronic stable angina , 2003 .
[21] E. Laakkonen,et al. Peripheral Vascular Disease as Predictor of Outcome after Coronary Artery Bypass Grafting , 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.
[22] R. Brant,et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. , 2001, JAMA.
[23] M. Criqui,et al. Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .
[24] W. Ghali,et al. Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. On behalf of the APPROACH investigators. , 2000, The Canadian journal of cardiology.
[25] M. A. Sellers,et al. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1999, Journal of the American College of Cardiology.
[26] H. Schaff,et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. , 1999, Circulation.
[27] N. Powe,et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[28] M. A. Sellers,et al. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1998, The American journal of cardiology.
[29] L. Kuller,et al. Mortality over Four Years in SHEP Participants with a Low Ankle‐Arm Index , 1997, Journal of the American Geriatrics Society.
[30] S. Flocke,et al. Intermittent claudication in 8343 men and 21-year specific mortality follow-up. , 1997, Annals of epidemiology.
[31] A. Lee,et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.
[32] J. Coresh,et al. Adjusting survival curves for confounders: a review and a new method. , 1996, American journal of epidemiology.
[33] J. Birkmeyer,et al. The effect of peripheral vascular disease on long-term mortality after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1996, Archives of surgery.
[34] M. Kornitzer,et al. Ankle/Arm Pressure Index in Asymptomatic Middle-Aged Males: An Independent Predictor of Ten-Year Coronary Heart Disease Mortality , 1995, Angiology.
[35] J. Birkmeyer,et al. The effect of peripheral vascular disease on in-hospital mortality rates with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1995, Journal of vascular surgery.
[36] B. Gersh,et al. Surgical therapy for coronary artery disease among patients with combined coronary artery and peripheral vascular disease. , 1995, Circulation.
[37] B. Gersh,et al. Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease , 1994 .
[38] L. Kuller,et al. Decreased ankle/arm blood pressure index and mortality in elderly women. , 1993, JAMA.
[39] L. Kuller,et al. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. , 1993, JAMA.
[40] J. Hallett. β-Adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: Radack K, Deck C. Arch Intern Med 1991;151:1769–1776 , 1993 .
[41] J. Ricco. Intermittent claudication, heart disease risk factors, and mortality: Smith GD, Shipley MJ, Rose G. Circulation 1990;82: 1925–1931 , 1992 .
[42] R. Langer,et al. Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.
[43] K. Radack,et al. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. , 1991, Archives of internal medicine.
[44] L. Kuller,et al. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. , 1991, Atherosclerosis.
[45] G. Dagenais,et al. Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.
[46] M J Shipley,et al. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. , 1990, Circulation.
[47] E. Varnauskas. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. , 1988, The New England journal of medicine.